Search

Your search keyword '"Wechalekar A"' showing total 197 results

Search Constraints

Start Over You searched for: Author "Wechalekar A" Remove constraint Author: "Wechalekar A" Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
197 results on '"Wechalekar A"'

Search Results

3. Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort

6. Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study

10. Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis

11. Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial

18. Search for AL amyloidosis risk factors using Mendelian randomization

20. Standardized reporting of monoclonal immunoglobulin–associated renal diseases: recommendations from a Mayo Clinic/Renal Pathology Society Working Group

21. Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA

23. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis

26. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles

30. Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome

31. IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation

34. Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein

36. Kiosk 1R-FB-04 - Cardiovascular Magnetic Resonance (CMR) in Transthyretin Amyloid Cardiomyopathy – a Study of Natural History of Treatment Response

38. Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

41. Native T1 Mapping in Transthyretin Amyloidosis

43. Efficacy and Safety of Belantamab Mafodotin Monotherapy in Patients with Relapsed or Refractory Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network

44. Use of Matrix-Assisted Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Free Light Chain Assessment for the Diagnosis and Monitoring of Systemic Immunoglobulin Light Chain (AL) Amyloidosis

48. Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial

Catalog

Books, media, physical & digital resources